Development of serine protease inhibitors displaying a multicentered short (<2.3 A) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa. [electronic resource]
- Journal of medicinal chemistry Aug 2001
- 2753-71 p. digital